Surrogacy, embryonic genetic screening and prevention of hereditary diseases

Surrogacy, beyond being a solution for infertility or certain medical circumstances, has also become a context where reproductive medicine achieves one of its highest levels of precision in the prevention of hereditary diseases through embryonic genetic screening. This article explores in depth how these three concepts—surrogacy, embryonic genetic screening, and the prevention of hereditary diseases—are related, explaining what they consist of, when they are applied, and what benefits they offer. If you are just beginning to learn about surrogacy, you will find a comprehensive, professional, and easy-to-understand overview here.

What is surrogacy and how is embryonic genetic screening integrated into it?

In this context, embryo genetic screening is integrated as a key tool before the embryo is transferred to the surrogate’s uterus. Its main objective is to analyze embryos obtained in the laboratory to identify possible genetic or chromosomal abnormalities.

During a surrogacy process, after the eggs are fertilized with sperm—whether from the intended parents or donors—the embryos develop for several days in the laboratory. It is at this point that embryonic genetic screening can be performed by extracting a small sample of cells from the embryo without compromising its viability.

This analysis allows for the selection of embryos with the highest implantation potential and free of certain hereditary diseases. This increases the likelihood of successful treatment and reduces the risk of transmitting genetic disorders.

It is important to understand that embryo genetic screening does not modify the embryo’s DNA, but rather acts as a diagnostic tool. Its function is to identify which embryos have optimal genetic characteristics for transfer, improving both the effectiveness of the treatment and the safety of the future baby.

How embryonic genetic screening helps in the prevention of hereditary diseases

The prevention of hereditary diseases is one of the most significant advances in modern reproductive medicine. Many genetic diseases are passed from parents to children without any prior obvious symptoms in either parent. This is especially true for recessive disorders, where both parents can be carriers without showing any signs of illness.

In this scenario, embryonic genetic screening allows for the detection of these abnormalities before pregnancy. There are different types of tests, including:

Preimplantation genetic diagnosis (PGD) is used when there is a known risk of transmitting a specific genetic disease. For example, if one or both parents carry a particular mutation, this test identifies which embryos are free of that mutation.

On the other hand, preimplantation genetic testing for aneuploidies (PGT-A) evaluates the number of chromosomes in the embryo. Chromosomal abnormalities can lead to conditions such as Down syndrome or cause implantation failure and miscarriages.

Thanks to these techniques, preventing hereditary diseases is no longer a matter of probability but an informed decision. In the context of surrogacy, where the process involves careful planning and a significant emotional and financial investment, this information becomes even more valuable.

Furthermore, embryonic genetic screening not only benefits the future baby but also the surrogate mother. By transferring genetically viable embryos, the risks of complications during pregnancy are reduced, contributing to a safer process for everyone involved.

It is important to note that these techniques are particularly indicated in certain cases, such as a family history of genetic diseases, advanced maternal age, previous implantation failures, or recurrent miscarriages. However, each situation must be evaluated individually by a specialized medical team.

Some more detailed articles, such as the following, can be found in our “Blog” section:

• Current medical criteria on embryo quality and success rates in surrogacy.
• Everything you need to know about Preimplantation Genetic Diagnosis.
• Success rates and medical considerations in surrogacy with frozen embryos.

Medical and emotional benefits of surrogacy

The combination of surrogacy and embryonic genetic screening offers benefits that extend beyond the clinical setting. From a medical perspective, one of the main objectives is to increase the treatment success rate.

By selecting genetically healthy embryos, the chances of implantation increase and the risk of miscarriage is reduced. This not only optimizes the process but also avoids the need for multiple attempts, which can be physically and emotionally draining.

Another important aspect is the reduction of uncertainty. Preventing hereditary diseases allows prospective parents to approach the process with greater peace of mind, knowing that steps have been taken to minimize risks.

From an emotional perspective, this point is especially important. Surrogacy involves a significant emotional burden, both for the intended parents and the surrogate. Having tools that provide security and confidence can make a substantial difference in the overall experience.

Furthermore, embryonic genetic screening contributes to more efficient planning of the process. By having detailed genetic information, the medical team can design more personalized strategies, adapted to the specific needs of each case.

However, it’s important to maintain realistic expectations. While these techniques increase the chances of success, they don’t guarantee absolute results. Human reproduction remains a complex process, influenced by multiple factors.

In this regard, information and professional support are essential. Understanding what embryonic genetic screening can offer and what its limitations are allows for more informed decisions that are aligned with each family’s goals.

Ethical considerations and informed decisions in the prevention of hereditary diseases

The use of genetic screening of embryos in surrogacy also raises ethical questions that must be addressed responsibly and transparently. The possibility of selecting embryos based on their genetic characteristics generates debates about the limits of medical intervention.

However, it is important to clearly distinguish between the prevention of hereditary diseases and other non-medical practices. The main objective of these techniques is to prevent the transmission of serious illnesses that could significantly affect the quality of life of the future baby.

In this context, embryonic genetic screening falls within the realm of preventive medicine, not as a tool for arbitrary selection. Its application is regulated in many countries and supervised by specialized professionals who ensure its ethical and appropriate use.

For intended parents, making decisions in this area can be complex. That’s why genetic counseling plays a vital role. This process allows them to understand the risks, the available options, and the implications of each decision.

During the counseling session, aspects such as family history, genetic testing results, and possible alternatives are analyzed. The goal is to provide clear and objective information, without pressure, so that each family can decide according to their values and circumstances.

Surrogacy, combined with embryonic genetic screening, represents an opportunity to move towards more conscious and safe reproduction. It’s not just about achieving a pregnancy, but about doing so under the best possible conditions, minimizing risks and promoting the well-being of the future child.

Ultimately, the prevention of hereditary diseases through these techniques reflects the progress of reproductive medicine and its ability to respond to increasingly specific needs. As technology continues to evolve, these tools are likely to become even more integrated into treatments, offering new possibilities to those who wish to start a family.

In conclusion

Surrogacy has evolved into much more than a reproductive alternative; today it represents an environment in which reproductive medicine can act preventively, precisely, and in a personalized manner. The integration of embryo genetic screening within this process marks a turning point in the approach to assisted reproduction, as it allows not only achieving pregnancy but also doing so under the best possible genetic conditions.

Thanks to these tools, the prevention of hereditary diseases is no longer solely a matter of chance but has become part of a conscious medical strategy. The ability to analyze embryos before transfer allows for the identification of those with greater viability and free from certain abnormalities, resulting in increased chances of success and a significant reduction in risks for both the future baby and the surrogate mother.

Furthermore, this approach offers undeniable emotional value. Surrogacy is a complex process involving dreams, investment, and significant decisions. In this context, having reliable genetic information provides peace of mind, reduces uncertainty, and allows intended parents to move forward with greater confidence and security.

However, it is crucial to understand that embryonic genetic screening is not a guarantee, but rather a tool that improves the odds within a biological process that remains complex. Therefore, the support of specialized professionals and genetic counseling are key to correctly interpreting the information and making informed and responsible decisions.

From an ethical perspective, its use must always remain within the framework of preventive medicine, aimed at preventing serious hereditary diseases and protecting the health of the future child. This regulated and supervised approach reinforces the idea that technology should serve well-being, not arbitrary selection.

In short, the combination of surrogacy, embryonic genetic screening, and prevention of hereditary diseases represents one of the most significant advances in assisted reproduction. It signifies a paradigm shift: it is no longer simply about achieving a pregnancy, but about doing so with the highest level of safety, knowledge, and responsibility, laying the foundation for more conscious and better-informed parenthood.